Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
NextCure Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
NXTC
Nasdaq
8731
https://www.nextcure.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for NextCure Inc
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
- May 2nd, 2024 8:05 pm
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
- Apr 24th, 2024 8:05 pm
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
- Apr 8th, 2024 11:00 am
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
- Apr 4th, 2024 11:05 am
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 11:00 am
Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?
- Mar 27th, 2024 10:46 am
Wall Street’s Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich
- Mar 23rd, 2024 10:00 am
NextCure to lay off 37% of staff, dial back research plans
- Mar 21st, 2024 3:22 pm
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
- Mar 21st, 2024 12:55 pm
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
- Mar 5th, 2024 1:05 pm
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
- Jan 18th, 2024 9:05 pm
Here's Why NextCure, Inc. (NXTC) Looks Ripe for Bottom Fishing
- Dec 25th, 2023 2:55 pm
NextCure Publishes Non-Clinical Data Demonstrating Anti-Siglec-15 Treatment Prevented Bone Loss Due to Immobilization from Acute Spinal Cord Injury
- Dec 21st, 2023 12:05 pm
NextCure (NXTC) Down on Shelving Plans to Develop Candidate
- Dec 15th, 2023 4:23 pm
NextCure Provides Year-End Clinical Pipeline Updates
- Dec 14th, 2023 11:45 am
NextCure to Present at the 35th Annual Piper Sandler Healthcare Conference
- Nov 20th, 2023 12:00 pm
NextCure Publishes Non-Clinical Data Defining the Mechanism of Action for NC525, a Novel LAIR-1 Antibody for AML
- Nov 15th, 2023 9:05 pm
All You Need to Know About NextCure, Inc. (NXTC) Rating Upgrade to Buy
- Nov 7th, 2023 5:00 pm
NextCure Inc (NXTC) Reports Q3 2023 Financial Results
- Nov 2nd, 2023 10:07 pm
NextCure Provides Business Update and Reports Third Quarter 2023 Financial Results
- Nov 2nd, 2023 8:05 pm
Scroll